Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on September 28, 2026

an hour ago

4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company’s Phase I Cell Therapy Program

Indeterminate GlobeNewswire

an hour ago

Pharmazz Completes Enrollment in 160-Patient Phase 4 Trial of Sovateltide in Acute Ischemic Stroke

Indeterminate GlobeNewswire

an hour ago

Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate

Indeterminate GlobeNewswire

an hour ago

Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine

Indeterminate GlobeNewswire

an hour ago

BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team

Indeterminate GlobeNewswire

an hour ago

BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer

Indeterminate GlobeNewswire

an hour ago

Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation

Indeterminate GlobeNewswire

an hour ago

Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026

Indeterminate GlobeNewswire

an hour ago

Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab

Indeterminate GlobeNewswire

an hour ago

Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules

Indeterminate GlobeNewswire

an hour ago

NOTICE TO DISREGARD -- Direct Meds

Indeterminate GlobeNewswire

2 hours ago

Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition

Indeterminate GlobeNewswire

2 hours ago

Flyte Named Official Air Travel Partner of the 34th Annual Hamptons International Film Festival

Indeterminate GlobeNewswire

2 hours ago

MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

Indeterminate GlobeNewswire

2 hours ago

Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

Indeterminate GlobeNewswire

3 hours ago

Lift Therapeutics Appoints Eva Ehrnrooth as Executive Head of Clinical Development and Adds Chau Khuong to Board of Directors

Indeterminate GlobeNewswire

4 hours ago

إطلاق نهج طبي دولي جديد رسمياً في شنتشن بالصينيهدف إلى عكس مسار السكري

Indeterminate GlobeNewswire

4 hours ago

A New International Medical Approach Aimed at Reversing Diabetes has Officially Launched in Shenzhen, China

Indeterminate GlobeNewswire

5 hours ago

Thermo Fisher Scientific and Evosep Enter Reseller Agreement for Evosep Eno

Indeterminate GlobeNewswire

5 hours ago

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition

Indeterminate GlobeNewswire